Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma(legacy) | 96 |
| Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma(legacy) | 69 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma | 0 | 6 | 0 | 3 | 0 | 1 | 3 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 54 |
| Germany | 13 |
| China | 12 |
| France | 8 |
| Netherlands | 8 |
| Australia | 5 |
| Vietnam | 5 |
| India | 1 |
| Japan | 1 |
| Sweden | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 25 |
| Rotterdam | 8 |
| Cambridge | 5 |
| Fairfield | 5 |
| Hanoi | 5 |
| Kaleen | 4 |
| Beijing | 3 |
| Boardman | 3 |
| Changchun | 3 |
| Zhengzhou | 3 |